Skip to Main Content

Paper Details

Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.
Ann Rheum Dis
4
2023
CCL3, CTX, CX3CL1, Cyclophosphamide, EGFR, EJ, IL-18, IL-22, IL-23, IL-27, IgG autoantibodies, La, SSB, Scleroderma, bactericidal permeability-increasing protein, cyclophosphamide, epidermal growth factor receptor, glycyl, glycyl-tRNA synthetase, haematopoietic stem cell, hepatitis, hepatitis B surface antigen, interferon-2A, interleukins, macrophage migration inhibitory factor, parietal cell antigen, participants, patients, protein antigens, scleroderma, stem cell factor, systemic sclerosis, transforming growth factor-, macrophage colony-stimulating factor, unique
Author NameAffiliation
Burcu AyogluStanford University School of Medicine
Michele DonatoStanford University School of Medicine
Michele DonatoStanford Institute for Immunity Transplantation and Infection
Leslie J CroffordVanderbilt University Medical Center
Maureen D MayesThe University of Texas Health Science Center
Purvesh KhatriStanford University School of Medicine
Purvesh KhatriStanford Institute for Immunity Transplantation and Infection
Purvesh KhatriStanford University School of Medicine
Purvesh KhatriStanford Institute for Immunity Transplantation and Infection
Paul J UtzStanford University School of Medicine
Paul J UtzStanford Institute for Immunity Transplantation and Infection
  • 1 - 11

Datasets

Release 1.2